Skip to main content

InforSense, GenomeQuest Sign Informatics Integration Pact

NEW YORK (GenomeWeb) - InforSense and GenomeQuest have agreed to integrate their software and database products to help customers analyze and share data in different domains, InforSense said today.
 
As part of the agreement, GenomeQuest has joined the InforSense Open Workflow Partner Network.
 
GenomeQuest's platform is used for analyzing sequence-based biological and patent content from private and public resources, while InforSense offers a workflow-based analytic technology.
 
InforSense said its customers will now be able to access GenomeQuest’s sequence and patent record databases through the InforSense platform.
 
The integrated solution will allow "attorneys, researchers, and business managers to identify promising research opportunities quickly and accurately," InforSense said.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.